Chemoinformaics analysis of 2-Ethyl-2-hydroxyhex-5-enol
| Molecular Weight | 144.214 | nRot | 5 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 10 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -4.656 | nHRing | 0 |
| Solubility: LogP | 7.462 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.6327 |
| nHD | 2 | BPOL | 16.0513 |
| QED | 0.07 |
| Synth | 4.499 |
| Natural Product Likeliness | 1.043 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.118 |
| HIA | 0.176 |
| CACO-2 | -5.346 |
| MDCK | 0.0000201 |
| BBB | 0.009 |
| PPB | 0.968216 |
| VDSS | 1.164 |
| FU | 0.0219482 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.364 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.065 |
| CYP2c9-sub | 0.961 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.112 |
| CYP3a4-sub | 0.018 |
| CL | 9.301 |
| T12 | 0.104 |
| hERG | 0.015 |
| Ames | 0.028 |
| ROA | 0.042 |
| SkinSen | 0.962 |
| Carcinogencity | 0.016 |
| EI | 0.011 |
| Respiratory | 0.196 |
| NR-Aromatase | 0.918 |
| Antiviral | No |
| Prediction | 0.940148 |